Abstract
Functional genomic imprinting is necessary for the transfer of maternal resources to mammalian embryos. Imprint-free embryos are unable to establish a viable placental vascular network necessary for the transfer of resources such as nutrients and oxygen. How the parental origin of inherited genes influences cellular response to resource limitation is currently not well understood. Because such limitations are initially realized by the placenta, we studied how maternal and paternal genomes influence the cellular self-destruction responses of this organ specifically. Here, we show that cellular autophagy is prevalent in androgenetic (i.e. having only a paternal genome) placentae, while apoptosis is prevalent in parthenogenetic (i.e. having only a maternal genome) placentae. Our findings indicate that the parental origin of inherited genes determines the placenta's cellular death pathway: autophagy for androgenotes and apoptosis for parthenogenotes. The difference in time of arrest between androgenotes and parthenogenotes can be attributed, at least in part, to their placentae's selective use of these two cell death pathways. We anticipate our findings to be a starting point for general studies on the parent-of-origin regulation of autophagy. Furthermore, our work opens the door to new studies on the involvement of autophagy in pathologies of pregnancy in which the restricted transfer of maternal resources is diagnosed.
Keywords: autophagy, cell death, uniparental embryo, placenta
2. Introduction
In mammals, maternal resources such as nutrients and oxygen are transferred to the embryo through a specialized organ, the placenta. The transfer of maternal resources is dependent on the correct functionality of genomic imprinting, a phenomenon that determines parental-specific gene expression [1]. Imprinted genes expressed from the paternally inherited copy increase resource transfer to the embryo, whereas maternally expressed genes reduce it [2]. Imprint-free embryos are unable to establish the correct placental vascular network. Without this network, the transfer of necessary resources is restricted, arresting the embryo's development [1,3,4]. Imprinting alterations are involved in human intrauterine growth restriction and other pathologies of pregnancy [5,6]. Knowing what strategies placentae use when faced with limited maternal resources may allow us to develop proper therapeutic measures for related placental dysfunctions.
To verify the subcellular features of placentae unable to establish contact with maternal vascularization, we used the animal model most relevant to human pregnancy studies, the sheep. The inability to establish contact with maternal vessels characterizes uniparental conceptuses, either androgenetic (AND), consisting of exclusively paternal genes, or parthenogenetic (PAR), having only maternal genes [7]. The relaxed imprinting of some genes notwithstanding, the general phenotype of AND and PAR embryos correlated with maternal- and paternal-imprint-free embryos, respectively [8]. Uni- and biparental embryos were produced in vitro and transferred to synchronized recipient sheep for further development using our previously described procedures [9–12].
3. Results and discussion
To determine first the extent of the growth and survival of uniparental (AND and PAR) sheep conceptuses versus bi-parental control (CTR) sheep conceptuses, these were collected at days 20, 22, 24 and 26 of development. No gross morphological differences between uni- and biparental conceptuses were noted under dissecting microscope at day 20 of development (figure 1a). Most of them developed to the 20 somite stage independently of their parental origin (figure 1b). However, there were differences in the survival of both models: AND conceptuses died prior to day 22, while PAR conceptuses died prior to day 26. PAR conceptuses isolated at days 22 and 24 were growth-retarded, as demonstrated by somite counting (figure 1b). On day 22 and 24 of development, the totality of PAR embryos reached the 20 somite stage, whereas the totality of biparental CTR embryos had already reached the 26 somite stage (figure 1b).
Furthermore, uniparental placentae at day 20 of development were similar in size (figure 2a) to the biparental controls. However, severe abnormalities in both uniparental models, in both the trophoblast and allantois compartments, were noted at the cellular level (figure 2a). The hyperproliferation of the terminally differentiated trophoblasts, together with the severely reduced vascular network in sheep AND placentae, confirms what has previously been observed in mouse [4,13]. On the other hand, the low number of trophoblast cells observed here in sheep PAR placentae were also observed in mouse PAR placentae [13,14]. As day 20 of sheep embryo development correlates with the establishment of fetal–maternal contact [15], plausibly, the subsequent death of sheep AND conceptuses and growth restriction of PAR conceptuses may be attributed to different placental defects in those models.
Imprinted genes have been shown to determine the transport capacity of the placenta by regulating its growth, morphology and nutrient abundance [16–18]. Bourc'his et al. [3] reported that imprint-free embryos are characterized by severe alteration of extraembryonic tissues. Indeed, uniparental embryos, carrying only either paternal (AND) or maternal (PAR) genes, cease development because of their inability to establish contact with maternal vascularization [1,19,20].
We wanted to know how paternal and maternal genomes influence cellular death in placentae that fail to establish functional connections with the maternal blood system. Maternal resource deprivation at day 20 of development did not diminish cellular viability in AND placentae while this caused massive cellular death in PAR placentae (figure 2b). Considering that death was more imminent for AND rather than PAR conceptuses, such a finding was surprising.
To verify how maternal and paternal genomes respond to nutritional restriction, we analysed placental ultrastructure using uniparental models. Distinct cellular morphologies of AND and PAR placentae were observed at day 20 of development (figure 3). PAR placentae had a twofold increase in the number of apoptotic cells (figure 3a), which is typical of the cell shrinkage and fragmentation process of the cytoplasm into apoptotic bodies. Both nuclear and cellular membranes in those cells lacked integrity and their chromatin was condensed (figure 3b). On the other hand, features characteristic of autophagy, such as vacuolization and an increased number of autophagosomes (i.e. double membrane vacuoles containing cytoplasmic content), swollen mitochondria together with maintained nuclear integrity, were less evident in PAR placentae (figure 3b). Furthermore, the expression of genes and proteins regulating autophagy was severely downregulated in PAR placentae (figure 4c,d). Conversely, severe deregulation of autophagy was noted in a majority of cells from AND placentae at day 20 of development (figure 3a). Autophagy or ‘self-eating’ is an intracellular degradation system, induced when cells are faced with nutritional stress. AND placental cells exhibited intense cytoplasmic vacuolization with numerous autophagosomes (figure 4a). Autophagosome accumulation in cell cytoplasm may reflect either the induction of the autophagic process or, alternatively, its block. One way to exclude that an increased number of autophagosomes may results from a block in the subsequent steps of autophagy is the direct estimation of the number of structures (i.e. autophagosomes and autolysosomes) involved in different steps of this process [21]. Apparently, the autophagy was increased, and not blocked, at any particular stage in AND placentae, as various stages of this process, starting from autophagosome formation through its fusion with lysosome and finally organelles digestion, were all observed with similar frequency (figure 4b). However, other analysis, such as LC3 turnover assay, would further strengthen our finding.
The expression of the majority of autophagy genes (figure 4c) and proteins (figure 4d) was upregulated in AND placentae. During autophagosome formation, initially a portion of cytoplasm, including organelles, is enclosed by the isolation membrane, and subsequently complete sequestration by the elongating membrane results in the formation of the mature autophagosome [22]. As demonstrated in figure 4c,d, autophagy markers involved in the different steps of autophagosome formation are deregulated.
The increased level of cellular autophagy in the placenta may protect the conceptus from nutritional stress [23]. The autophagy eliminates cellular structures and releases the breakdown products as nutrients that can be reused by the cell or exported for use by other cells [24]. Therefore, an increased autophagy in AND placentae may suggest that the paternal genome: (i) generally protects the embryo from growth restriction, and (ii) specifically protects the embryonic cells from apoptosis, as autophagy is a counterstrategy against the irreversible apoptotic signal [25]. On the other hand, the autophagy may constitute an alternative cell death pathway [22,26]. It appears that in some cellular settings, the switch between the two responses (autophagy and apoptosis) occurs in a mutually exclusive manner [27,28].
The parental contribution effect on autophagy has never before been studied. Here, we show that the AND placenta augments cellular autophagy once it is not able to transmit nutrients to the embryo, while a similar nutritional restriction will induce cell death (apoptosis) in the PAR placenta. It has been recently demonstrated that a cell whose entire genome is maternal is characterized by early cessation of cellular growth and subsequent death, while a paternal genome cell shows enhanced growth and transformation [29,30]. Downregulation of autophagy in PAR placentae is related to the involvement of paternally inherited genes in this process. At least one gene required for autophagy induction, the aplasia Ras homologue member I (ARHI), is known to be maternally imprinted [31,32]. Therefore, cells having diploid paternal DNA will overexpress ARHI, as exhaustively demonstrated in AND placentae (figure 4c). In turn, downregulation of apoptosis in AND placentae is related to the regulation of this type of cellular death, at least in part, by maternally inherited genes. The overexpression of the paternally imprinted gene PHLDA2 was recently found to induce apoptosis through caspase cascade activation [33]. In our study, a PHLDA2 transcript was not detectable in AND placentae though it was shown to be upregulated in PAR placentae (1.64-fold over CTR; p < 0.05). With relevance to the aberrant trophoblast layer in uniparental placentae, PHLDA2 has also been found to affect trophoblast differentiation [34,35].
PAR placentae, which lack a paternal genome and are thus incapable of autophagy, activate an alternative cellular self-destruction pathway, that of apoptosis. AND placentae use their own cellular resources to avoid the reduction in the conceptus's growth that is observed in their autophagy-deficient counterparts, PAR placentae. However, the maximal induction of autophagy in AND placentae leads to the rapid depletion of key molecules and organelles, triggering autophagic cell death [36]. Therefore, the increased placental autophagy in AND conceptuses results in their sudden death. The gradual decrease in embryo size that accompanies the last days of development of PAR conceptuses does not occur.
The survival of sheep AND and PAR conceptuses corresponds to that in the mouse, which goes through the same developmental stages. In mouse, a specific lack of maternal imprints leads to conceptus lethality at 9.5 days post-coitum (dpc), while a lack of paternal imprints, at 13.5 dpc [1,3]. It has been recently suggested that paternal imprints may not be essential for the establishment of fetal–maternal interphase or that their effect becomes apparent later on, as paternal-imprint-free embryos survive longer than their maternal-imprint-free counterparts [1]. Besides the differences between maternal- and paternal-imprint-free placental development, our study suggests that the different timing of embryonic death in maternal- and paternal-imprint-free embryos is, at least in part, due to divergent cellular death strategies.
In the light of our findings, it appears that the maternal genome drives the development of the embryo only when an adequate transfer of resources is guaranteed. By contrast, the paternal genome seeks the survival of the conceptus ‘at all costs’, and therefore uses autophagy as a rescue strategy. Such an interpretation is in agreement with the imprinting hypothesis about excessive utilization of available resources directed by the paternal genome and the protection against it from the maternal counterpart [37].
Studies on placental cell death during pregnancy complications such as intrauterine growth restriction and pre-eclampsia have thus far focused exclusively on apoptosis [38]. However, as we have shown, autophagy is also involved as a mechanism in placental cell destruction. As imprinting disorders are involved in the aetiology of these pregnancy complications, understanding the underlying control of autophagy in pathological placentae, in addition to apoptosis, is necessary to paint the complete picture of how placental cell death leads to conceptus growth aberrancies.
4. Material and methods
4.1. Embryo production
In vitro embryo production methods were adapted from those previously described [12,39]. Briefly, ovaries were obtained from the abattoir. Collected oocytes were matured in bicarbonate-buffered TCM-199, supplemented with 2 mM l-glutamine, 100 mM cysteamine, 0.3 mM sodium pyruvate, 5 g ml−1 FSH (Ovagen, ICP, Auckland, New Zealand), 5 g ml−1 LH, 1 g ml−1 17-β-oestradiol and 10% fetal bovine serum under 5% CO2 at 38.5°C for 24 h. For parthenogenetic embryo production, in vitro matured oocytes were activated with a combined treatment of ionomycin and 6-dimethylaminopurine, in synthetic oviductal fluid (SOF) medium, as previously described [9]. For androgenetic embryo production, the embryos were produced by in vitro fertilization of enucleated metaphase II oocytes as previously described [10]. For in vitro fertilized embryo production, partially denuded matured oocytes were transferred into 50 µl drops of bicarbonate-buffered SOF enriched with 2% (v : v) heat-inactivated estrous sheep serum, 2.9 mM calcium lactate and 16 mM isoproterenol. Fertilization with frozen–thawed ram semen was carried out at a final concentration of 5 × 106 sperm ml−1, and fertilized eggs were kept in 5% CO2 at 38.5°C overnight. For embryo culture, all classes of embryos were transferred into 20 µl drops of SOF enriched with 1% (v : v) Basal Medium Eagle essential amino acids, 1% (v : v) Minimum Essential Medium, non-essential amino acids (Gibco), 1 mM glutamine and 8 mg ml−1 fatty-acid-free BSA (SOFaa-BSA). Embryos were cultured in a humidified atmosphere of 5% CO2, 7% O2, 88% N2 at 38.5°C, and the medium changed at day 3 and day 5.
4.2. Embryo transfer and recovery samples
All animal experiments were performed in accordance with DPR 27/1/1992 (Italian Animal Protection Regulation) and conformed to the European Community regulation 86/609. Embryo transfer (ET) and sample recovery were carried out as previously described [12]. Placentae (chorionallantoid tissues) from live fetuses were snap-frozen in liquid nitrogen or fixed for subsequent analysis. A total of 56 CTR, 28 AND and 43 PAR fetuses and their placentae were recovered from 50 Sardinian sheep.
4.3. Gene expression analysis
Expression analysis was carried out as previously described [12]. Total RNA integrity was assessed by a 2100 Bioanalyzer (Agilent Technologies, Waldbronn, Germany). Samples with an RNA integrity number of at least 8.5 were reverse-transcribed and used for gene expression analysis with specific primer pairs (LC3 (JQ035664.1) FW: 5′-atggtatacgcctctcagg-3′, RV: 5′-ttcccaaagctgaatgtgc-3′; ATG5 (JQ035661.1) FW: 5′-aaggaccttctacactgtcc-3′, RV: 5′-atctgtagacacaggtcg-3′; ATG9 (JQ035663.1) FW: 5′-aagacgtgctggctgtgg-3′, RV: 5′-ttgtactggaagagctgg-3′; ATG6 (JQ035662.1) FW: 5′-ttgaaactcgccaggatgg-3′, RV: 5′-ttgagctgagtgtccagc-3′; AMBRA1 (NM_001034522) FW: 5′-atctgggatttacacggtgg-3′, RV: 5′-ttgctgtgagtaagtagtgtcc-3′; ARHI (NM_001127282.1) FW: 5′-gaaggaaggtgctgcctatg-3′, RV: 5′-gtcttggggatctgggattt-3′; RAB7 (NM_001035081.1) FW: 5′-ctgacgaaggaggtgatggt-3′, RV: 5′-aagggtcttgaacgtgttgg-3′; β-actin (NM_001009784) FW: 5′-aatcgtccgtgacatcaag-3′, RV: 5′-ttcatgatggaattgaagg-3′).
4.4. Immunohistochemistry and TUNEL assay
Twenty-day placental tissues were fixed overnight in 4% paraformaldehyde, and 5 µm sections were used for immunohistochemistry and TUNEL assay. Different primary antibodies were incubated: LC-3, 4 μg ml−1 (ab58610); ULK-1, 1 : 1000 (ab65056); and Rab-7, 10 μg ml−1 (ab77993) (all from Abcam, Cambridge, UK). Antibody binding was visualized using Universal LSAB (Dako, Glostrup, Denmark). Also, 5 µm sections were TUNEL assayed using ApopTag fluorescein kit (Millipore, MA, USA) according to the manufacturer's protocol. Immunohistochemistry images were captured using the Nikon Eclipse E600 light microscope (Nikon, Melville, NY, USA), while TUNEL assay images were obtained using confocal microscope Laser Sharp 2000 (Biorad, Milan, Italy).
4.5. Transmission electron microscopy
Placental tissues were fixed in 2.5% glutaraldehyde for 24 h and postfixed in 2% OsO4 for 4 h. Samples were dehydrated through a graded series of ethanol and infiltrated with Epon resin in 100% acetone, infused twice for 1 h in pure epon resin and polymerized for 24 h at 65°C; 60 nm sections were examined on a LEO 912AB electron microscope (Leo Electron, Thornwood, NY, USA). Images were captured by the Slow Scan CCD (Proscane) using EsiVision Pro v. 3.2 software (Soft Imaging Systems GmbH).
4.6. Statistical analysis
Statistical analysis was performed using Instat 5 (GraphPad Software for Science, San Diego, CA, USA). Data reported are the mean ± s.e.m. and were analysed using the non-parametric Mann–Whitney t-test (figure 4a,c). Data expressed as percentages were analysed using the Fisher's exact test (figure 3a) or χ2-test (figure 2b). Only p-values < 0.05 were considered significant.
Acknowledgements
G.E.P. designed the experiments and wrote the paper. M.C., P.T. and A.F. performed the experiments and analysed the data. F.Z. provided all embryo models. J.A.M. and P.L. interpreted the data and edited the paper. All authors discussed the results and implications and commented on the manuscript at all stages.
Funding statement
This work was supported by the European Research Council/Programme IDEAS (FP7/2007–2013, GA no. 210103) to G.E.P.
References
- 1.Schulz R, Proudhon C, Bestor TH, Woodfine K, Lin CS, Lin SP, Prissette M, Oakey RJ, Bourc'his D. 2010. The parental non-equivalence of imprinting control regions during mammalian development and evolution. PLoS Genet. 6, e1001214 (doi:10.1371/journal.pgen.1001214) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Constância M, Kelsey G, Reik W. 2004. Resourceful imprinting. Nature 432, 53–57. (doi:10.1038/432053a) [DOI] [PubMed] [Google Scholar]
- 3.Bourc'his D, Xu GL, Lin CS, Bollman B, Bestor TH. 2001. Dnmt3L and the establishment of maternal genomic imprints. Science 294, 2536–2539. (doi:10.1126/science.1065848) [DOI] [PubMed] [Google Scholar]
- 4.Bourc'his D, Proudhon C. 2008. Sexual dimorphism in parental imprint ontogeny and contribution to embryonic development. Mol. Cell. Endocrinol. 282, 87–94. (doi:10.1016/j.mce.2007.11.025) [DOI] [PubMed] [Google Scholar]
- 5.Diplas AI, Lambertini L, Lee MJ, Sperling R, Lee YL, Wetmur J, Chen J. 2009. Differential expression of imprinted genes in normal and IUGR human placentas. Epigenetics 4, 235–240. [DOI] [PubMed] [Google Scholar]
- 6.Yu L, et al. 2009. The H19 gene imprinting in normal pregnancy and pre-eclampsia. Placenta 30, 443–447. (doi:10.1016/j.placenta.2009.02.011) [DOI] [PubMed] [Google Scholar]
- 7.Dean WL, Kelsey G, Reik W. 2001. Genomic imprinting: methods and protocols. In Methods of molecular biology (ed. Ward A.), vol. 181, pp. 1–20 Totowa, NJ: Human Press Inc. [DOI] [PubMed] [Google Scholar]
- 8.Ogawa H, Wu Q, Komiyama J, Obata Y, Kono T. 2006. Disruption of parental-specific expression of imprinted genes in uniparental fetuses. FEBS Lett. 580, 5377–5384. (doi:10.1016/j.febslet.2006.08.087) [DOI] [PubMed] [Google Scholar]
- 9.Loi P, Ledda S, Fulka J, Jr, Cappai P, Moor RM. 1998. Developmental of parthenogenetic and cloned ovine embryos: effect of activation protocols. Biol. Reprod. 58, 1177–1187. (doi:10.1095/biolreprod58.5.1177) [DOI] [PubMed] [Google Scholar]
- 10.Zacchini F, Czernik M, Iuso D, Toschi P, di Egidio F, Scapolo PA, Loi P, Ptak G. 2011. Efficient production and cellular characterization of sheep androgenetic embryos. Cell Reprogram 13, 495–502. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Turco MY, et al. 2008. High levels of anandamide, an endogenous cannabinoid, block the growth of sheep preimplantation embryos by inducing apoptosis and reversible arrest of cell proliferation. Hum. Reprod. 23, 2331–2338. (doi:10.1093/humrep/den258) [DOI] [PubMed] [Google Scholar]
- 12.Ptak GE, D'Agostino A, Toschi P, Fidanza A, Zacchini F, Czernik M, Monaco F, Loi P. 2013. Post-implantation mortality of in vitro produced embryos is associated with DNA methyltransferase 1 dysfunction in sheep placenta. Hum. Reprod. 28, 298–305. (doi:10.1093/humrep/des397) [DOI] [PubMed] [Google Scholar]
- 13.Surani MA, Barton SC, Norris ML. 1984. Development of reconstituted mouse eggs suggests imprinting of the genome during gametogenesis. Nature 308, 548–550. (doi:10.1038/308548a0) [DOI] [PubMed] [Google Scholar]
- 14.Surani MA, Reik W, Norris ML, Barton SC. 1986. Influence of germline modifications of homologous chromosomes on mouse development. J. Embryol. Exp. Morphol. 97, 123–136. [PubMed] [Google Scholar]
- 15.Guillomot M, Fléchon JE, Wintenberger-Torres S. 1981. Conceptus attachment in the ewe: an ultrastructural study. Placenta 2, 169–182. (doi:10.1016/S0143-4004(81)80021-5) [DOI] [PubMed] [Google Scholar]
- 16.Reik W, Constância M, Fowden A, Anderson N, Dean W, Ferguson-Smith A, Tycko B, Sibley C. 2003. Regulation of supply and demand for maternal nutrients in mammals by imprinted genes. J. Physiol. 547, 35–44. (doi:10.1113/jphysiol.2002.033274) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Burton GJ, Fowden AL. 2012. Review: the placenta and developmental programming: balancing fetal nutrient demands with maternal resource allocation. Placenta 33, 23–27. (doi:10.1016/j.placenta.2011.11.013) [DOI] [PubMed] [Google Scholar]
- 18.Fowden AL, Sibley C, Reik W, Constancia M. 2006. Imprinted genes, placental development and fetal growth. Horm. Res. 65, 50–58. (doi:10.1159/000091506) [DOI] [PubMed] [Google Scholar]
- 19.Barton SC, Surani MA, Norris ML. 1984. Role of paternal and maternal genomes in mouse development. Nature 311, 374–376. (doi:10.1038/311374a0) [DOI] [PubMed] [Google Scholar]
- 20.Arima T, Hata K, Tanaka S, Kusumi M, Li E, Kato K, Shiota K, Sasaki H, Wake N. 2006. Loss of the maternal imprint in Dnmt3Lmat−/− mice leads to a differentiation defect in the extraembryonic tissue. Dev. Biol. 297, 361–373. (doi:10.1016/j.ydbio.2006.05.003) [DOI] [PubMed] [Google Scholar]
- 21.Mizushima N, Yoshimori T, Levine B. 2010. Methods in mammalian autophagy research. Cell 140, 313–326. (doi:10.1016/j.cell.2010.01.028) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Mariño G, Niso-Santano M, Baehrecke EH, Kroemer G. 2014. Self-consumption: the interplay of autophagy and apoptosis. Nat. Rev. Mol. Cell. Biol. 152, 81–94. (doi:10.1038/nrm3735) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Broad KD, Keverne EB. 2011. Placental protection of the fetal brain during short-term food deprivation. Proc. Natl Acad. Sci. USA 108, 15 237–15 241. (doi:10.1073/pnas.1106022108) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Neufeld TP. 2012. Autophagy and cell growth: the yin and yang of nutrient responses. J. Cell. Sci. 125, 2359–2368. (doi:10.1242/jcs.103333) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Kroemer G, Jäättelä M. 2005. Lysosomes and autophagy in cell death control. Nat. Rev. Cancer 5, 886–897. (doi:10.1038/nrc1738) [DOI] [PubMed] [Google Scholar]
- 26.Maiuri C, Zalckvar E, Kimchi A, Kroemer G. 2007. Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat. Rev. Mol. Cell. Biol. 8, 741–752. (doi:10.1038/nrm2239) [DOI] [PubMed] [Google Scholar]
- 27.Mizushima N, Levine B, Cuervo AM, Klionsky DJ. 2008. Autophagy fights disease through cellular self-digestion. Nature 451, 1069–1075. (doi:10.1038/nature06639) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Levine B, Yuan J. 2005. Autophagy in cell death: an innocent convict? J. Clin. Invest. 115, 2679–2688. (doi:10.1172/JCI26390) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Hernandez L, Kozlov S, Piras G, Stewart CL. 2003. Paternal and maternal genomes confer opposite effects on proliferation, cell-cycle length, senescence, and tumor formation. Proc. Natl Acad. Sci. USA 100, 13 344–13 349. (doi:10.1073/pnas.2234026100) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Surani MA, Kothary R, Allen ND, Singh PB, Fundele R, Ferguson-Smith AC, Barton SC. 1990. Genome imprinting and development in the mouse. Dev. Suppl. 108, 89–98. [PubMed] [Google Scholar]
- 31.Zou CF, et al. 2011. Re-expression of ARHI (DIRAS3) induces autophagy in breast cancer cells and enhances the inhibitory effect of paclitaxel. BMC Cancer 19, 11–22. (doi:10.1186/1471-2407-11-22) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Lu Z, et al. 2008. The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells. J. Clin. Invest. 118, 3917–3929. (doi:10.1172/JCI35512) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Huang Y, Dai H, Guo QN. 2012. TSSC3 overexpression reduces stemness and induces apoptosis of osteosarcoma tumor-initiating cells. Apoptosis 17, 1–13. (doi:10.1007/s10495-011-0661-6) [DOI] [PubMed] [Google Scholar]
- 34.Salas M, John R, Saxena A, Barton S, Frank D, Fitzpatrick G, Higgins MJ, Tycko B. 2004. Placental growth retardation due to loss of imprinting of Phlda2. Mech. Dev. 121, 1199–1210. (doi:10.1016/j.mod.2004.05.017) [DOI] [PubMed] [Google Scholar]
- 35.Frank D, et al. 2002. Placental overgrowth in mice lacking the imprinted gene Ipl. Proc. Natl Acad. Sci. USA 99, 7490–7495. (doi:10.1073/pnas.122039999) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Shintani T, Klionsky DJ. 2004. Autophagy in health and disease: a double-edged sword. Science 306, 990–995. (doi:10.1126/science.1099993) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Moore T, Haig D. 1991. Genomic imprinting in mammalian development: a parental tug-of-war. Trends Genet. 7, 45–49. (doi:10.1016/0168-9525(91)90230-N) [DOI] [PubMed] [Google Scholar]
- 38.Scifres CM, Nelson DM. 2009. Intrauterine growth restriction, human placental development and trophoblast cell death. J. Physiol. 587, 3453–3458. (doi:10.1113/jphysiol.2009.173252) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Ptak G, Clinton M, Tischner M, Barboni B, Mattioli M, Loi P. 2002. Improving delivery and offspring viability of in vitro-produced and cloned sheep embryos. Biol. Reprod. 67, 1719–1725. (doi:10.1095/biolreprod.102.006171) [DOI] [PubMed] [Google Scholar]